EUVIMEDOpdag EUVIMED
Crossref

Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib

Ebru Hacıosmanoğlu-Aldoğan, Dilhan Lama, Hande İpek Yetke, Halil Şenol, Fulya Dal Yöntem

Cell Biochemistry and Function · 2025-03 · 43 (3)

DOI: 10.1002/cbf.70068 ↗

At a glance

Journal article in Cell Biochemistry and Function, published online on 2025-03-13. Written by Ebru Hacıosmanoğlu-Aldoğan and 4 co-authors. Institution: Department of Biophysics, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Fatih, Istanbul, Türkiye. Major MEDLINE topics: Cell Movement, Cell Proliferation, Lung Neoplasms, Aminopyridines. Cited 6 times so far (Crossref); 43 references. Funded by: This study was supported by Bezmialem Vakif Üniversitesi (20220402E)..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In this study, the cytotoxic effects of pexidartinib (PLX), a tyrosine kinase inhibitor approved for tenosynovial giant cell tumor through inhibition of colony‐stimulating factor 1 receptor (CSF1R), against A549 lung adenocarcinoma cells and Beas‐2B healthy bronchial cells were investigated by in detailed in‐vitro and in‐silico studies. Through MTT assays, PLX demonstrated significant inhibition of A549 cell viability with IC 50 values of 2.15 and 1.3 µM at 24 and 48 h, respectively, while having minimal effects on Beas‐2B cells, with IC 50 values of 36.2 and 9.3 µM. The high selectivity index indicates PLX's preferential action against cancerous cells. The mechanism of cell death induced by PLX was further explored using Annexin V/PI staining and flow cytometry, revealing that PLX primarily induces necrosis in A549 cells, with an increase in necrotic cell populations and reduced efficacy at higher concentrations. Western blot analysis showed an upregulation of necroptosis markers (RIP3 and pMLKL) in A549 cells, while apoptotic markers like Caspase‐3 remained unchanged. In addition, wound healing assays demonstrated that PLX significantly inhibits A549 cell migration in a dose‐dependent manner. Molecular docking studies identified key amino acids involved in PLX binding interactions with target proteins. RIPK1 showed the strongest binding affinity. MD simulations revealed that the PLX‐VEGFR2 complex was the most stable. As conclusion, PLX, although approved for tenosynovial giant cell tumors, shows promising potential for lung adenocarcinoma treatment. It selectively inhibits cancer cell viability, induces necroptosis, and reduces cell migration. Its stronger binding to RIPK1 and VEGFR2 more than CSF1R.

Subjects

MeSH terms (MEDLINE)

Cell MovementCell ProliferationLung NeoplasmsAminopyridinesNecroptosisPyrrolesAntineoplastic AgentsProtein Kinase InhibitorsHumansMolecular Docking SimulationA549 CellsCell Survival

Author keywords

lung cancermolecular dockingmolecular dynamicsnecroptosispexidartinibtyrosine kinase inhibitor

Substances

AminopyridinespexidartinibPyrrolesAntineoplastic AgentsProtein Kinase Inhibitors

Authors and institutions

  • Department of Biophysics, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Fatih, Istanbul, Türkiye.
  • Faculty of Medicine, Bezmialem Vakif University, Fatih, Istanbul, Türkiye.
  • Department of Biophysics, Faculty of Medicine, Bezmialem Vakif University, Fatih, Istanbul, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University, Fatih, Istanbul, Türkiye.
  • Department of Biophysics, School of Medicine, Koç University, Sarıyer, Istanbul, Türkiye.
  • Koç University Research Center for Translational Medicine (KUTTAM), Sarıyer, Istanbul, Türkiye.

Funding

  • This study was supported by Bezmialem Vakif Üniversitesi (20220402E).

Cite

APA

Hacıosmanoğlu-Aldoğan, E., Lama, D., Yetke, H. İ., Şenol, H., & Yöntem, F. D. (2025). Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib. Cell Biochemistry and Function, 43(3). https://doi.org/10.1002/cbf.70068

Vancouver

Hacıosmanoğlu-Aldoğan E, Lama D, Yetke Hİ, Şenol H, Yöntem FD. Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib. Cell Biochemistry and Function. 2025;43(3). doi:10.1002/cbf.70068

BibTeX
@article{HacosmanoluAldoan2025,
  author = {Hacıosmanoğlu-Aldoğan, Ebru and Lama, Dilhan and Yetke, Hande İpek and Şenol, Halil and Yöntem, Fulya Dal},
  title = {Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib},
  journal = {Cell Biochemistry and Function},
  year = {2025},
  volume = {43},
  number = {3},
  doi = {10.1002/cbf.70068}
}
Start for free →